Clinical Trial: A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory Treatment

U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07025811) titled 'A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory Treatment' on June 16.

Brief Summary: This study aims to evaluate the performance of biomarkers and their responsiveness to standard-of-care treatments (Vevye(R) or Xiidra(R)), in participants with dry eye disease (DED) compared to healthy volunteers (control participants).

Study Start Date: July 31

Study Type: INTERVENTIONAL

Condition: Dry Eye Disease

Intervention: DRUG: Vevye(R)

Participants will receive Vevye(R) (0.1% cyclosporine ophthalmic solution) as per the schedule described in the treatment arm.

DRUG: Xiid...